ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF

ALTERITY THERAPEUTICS LTD

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026

$2.43−0.19 (-7.25%)

Close on Oct 19, 2026

ALTERITY THERAPEUTICS LTD revenue by segment

Alterity Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.